Three immunotherapy drugs approved for the treatment of melanoma may be used to treat advanced lung, liver, head and neck, and colorectal cancers, according to clinical trial results presented at the 2015 American Society of Clinical Oncology annual meeting in Chicago.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
